Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2018-10, Vol.29, p.viii62-viii62
Hauptverfasser: De Nonneville, A., Jauffret, C., Gonçalves, A., Classe, J.-M., Cohen, M., Reyal, F., Mazouni, C., Chauvet, M.-P., Chopin, N., Colombo, P.-E., Jouve, E., Darai, E., Rouzier, R., Coutant, C., Gimbergues, P., Azuar, A.-S., Tunon de Lara, C., Lambaudie, E., Houvenaeghel, G.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page viii62
container_issue
container_start_page viii62
container_title Annals of oncology
container_volume 29
creator De Nonneville, A.
Jauffret, C.
Gonçalves, A.
Classe, J.-M.
Cohen, M.
Reyal, F.
Mazouni, C.
Chauvet, M.-P.
Chopin, N.
Colombo, P.-E.
Jouve, E.
Darai, E.
Rouzier, R.
Coutant, C.
Gimbergues, P.
Azuar, A.-S.
Tunon de Lara, C.
Lambaudie, E.
Houvenaeghel, G.
description
doi_str_mv 10.1093/annonc/mdy270.190
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdy270_190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419486183</els_id><sourcerecordid>32137666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2300-1744eb4bfbed2278107a2fedc5fb2d7d86402a7043aa481d82d11b975ddfc6fa3</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMobk5_gDeSH2BdknZNi1c65gcMBNHrcpqcuIw1KUlX2L-3o-qlV-eD933P4SHkmrM7zsp0Ds55p-aNPgg5rEp2QqZ8kZdJwTJ-SqasFGkiF2k2IRcxbhljeSnKczJJBU9lnudT0j-iQ2M76g0Fvd334DqqNtj4boMB2gO1jm58aLxDGlBh2_mQtD7azvZ4S19W7yJx-AXjaF0Pcejoztf7HQSqICjrfAPHA0MkrQNC7C7JmYFdxKufOiOfT6uP5Uuyfnt-XT6sEyVSxhIuswzrrDY1aiFkwZkEYVCrhamFlrrIMyZAsiwFyAquC6E5r0u50Nqo3EA6I3zMVcHHGNBUbbANhEPFWXVkWI0Mq5FhNTAcPDejp93XDeo_xy-0QXA_CnD4vLcYqqgsOoXaDoS6Snv7T_w3x66HGg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>De Nonneville, A. ; Jauffret, C. ; Gonçalves, A. ; Classe, J.-M. ; Cohen, M. ; Reyal, F. ; Mazouni, C. ; Chauvet, M.-P. ; Chopin, N. ; Colombo, P.-E. ; Jouve, E. ; Darai, E. ; Rouzier, R. ; Coutant, C. ; Gimbergues, P. ; Azuar, A.-S. ; Tunon de Lara, C. ; Lambaudie, E. ; Houvenaeghel, G.</creator><creatorcontrib>De Nonneville, A. ; Jauffret, C. ; Gonçalves, A. ; Classe, J.-M. ; Cohen, M. ; Reyal, F. ; Mazouni, C. ; Chauvet, M.-P. ; Chopin, N. ; Colombo, P.-E. ; Jouve, E. ; Darai, E. ; Rouzier, R. ; Coutant, C. ; Gimbergues, P. ; Azuar, A.-S. ; Tunon de Lara, C. ; Lambaudie, E. ; Houvenaeghel, G.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdy270.190</identifier><identifier>PMID: 32137666</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Annals of oncology, 2018-10, Vol.29, p.viii62-viii62</ispartof><rights>2018 THE AUTHORS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32137666$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Nonneville, A.</creatorcontrib><creatorcontrib>Jauffret, C.</creatorcontrib><creatorcontrib>Gonçalves, A.</creatorcontrib><creatorcontrib>Classe, J.-M.</creatorcontrib><creatorcontrib>Cohen, M.</creatorcontrib><creatorcontrib>Reyal, F.</creatorcontrib><creatorcontrib>Mazouni, C.</creatorcontrib><creatorcontrib>Chauvet, M.-P.</creatorcontrib><creatorcontrib>Chopin, N.</creatorcontrib><creatorcontrib>Colombo, P.-E.</creatorcontrib><creatorcontrib>Jouve, E.</creatorcontrib><creatorcontrib>Darai, E.</creatorcontrib><creatorcontrib>Rouzier, R.</creatorcontrib><creatorcontrib>Coutant, C.</creatorcontrib><creatorcontrib>Gimbergues, P.</creatorcontrib><creatorcontrib>Azuar, A.-S.</creatorcontrib><creatorcontrib>Tunon de Lara, C.</creatorcontrib><creatorcontrib>Lambaudie, E.</creatorcontrib><creatorcontrib>Houvenaeghel, G.</creatorcontrib><title>Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMobk5_gDeSH2BdknZNi1c65gcMBNHrcpqcuIw1KUlX2L-3o-qlV-eD933P4SHkmrM7zsp0Ds55p-aNPgg5rEp2QqZ8kZdJwTJ-SqasFGkiF2k2IRcxbhljeSnKczJJBU9lnudT0j-iQ2M76g0Fvd334DqqNtj4boMB2gO1jm58aLxDGlBh2_mQtD7azvZ4S19W7yJx-AXjaF0Pcejoztf7HQSqICjrfAPHA0MkrQNC7C7JmYFdxKufOiOfT6uP5Uuyfnt-XT6sEyVSxhIuswzrrDY1aiFkwZkEYVCrhamFlrrIMyZAsiwFyAquC6E5r0u50Nqo3EA6I3zMVcHHGNBUbbANhEPFWXVkWI0Mq5FhNTAcPDejp93XDeo_xy-0QXA_CnD4vLcYqqgsOoXaDoS6Snv7T_w3x66HGg</recordid><startdate>201810</startdate><enddate>201810</enddate><creator>De Nonneville, A.</creator><creator>Jauffret, C.</creator><creator>Gonçalves, A.</creator><creator>Classe, J.-M.</creator><creator>Cohen, M.</creator><creator>Reyal, F.</creator><creator>Mazouni, C.</creator><creator>Chauvet, M.-P.</creator><creator>Chopin, N.</creator><creator>Colombo, P.-E.</creator><creator>Jouve, E.</creator><creator>Darai, E.</creator><creator>Rouzier, R.</creator><creator>Coutant, C.</creator><creator>Gimbergues, P.</creator><creator>Azuar, A.-S.</creator><creator>Tunon de Lara, C.</creator><creator>Lambaudie, E.</creator><creator>Houvenaeghel, G.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201810</creationdate><title>Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast</title><author>De Nonneville, A. ; Jauffret, C. ; Gonçalves, A. ; Classe, J.-M. ; Cohen, M. ; Reyal, F. ; Mazouni, C. ; Chauvet, M.-P. ; Chopin, N. ; Colombo, P.-E. ; Jouve, E. ; Darai, E. ; Rouzier, R. ; Coutant, C. ; Gimbergues, P. ; Azuar, A.-S. ; Tunon de Lara, C. ; Lambaudie, E. ; Houvenaeghel, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2300-1744eb4bfbed2278107a2fedc5fb2d7d86402a7043aa481d82d11b975ddfc6fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Nonneville, A.</creatorcontrib><creatorcontrib>Jauffret, C.</creatorcontrib><creatorcontrib>Gonçalves, A.</creatorcontrib><creatorcontrib>Classe, J.-M.</creatorcontrib><creatorcontrib>Cohen, M.</creatorcontrib><creatorcontrib>Reyal, F.</creatorcontrib><creatorcontrib>Mazouni, C.</creatorcontrib><creatorcontrib>Chauvet, M.-P.</creatorcontrib><creatorcontrib>Chopin, N.</creatorcontrib><creatorcontrib>Colombo, P.-E.</creatorcontrib><creatorcontrib>Jouve, E.</creatorcontrib><creatorcontrib>Darai, E.</creatorcontrib><creatorcontrib>Rouzier, R.</creatorcontrib><creatorcontrib>Coutant, C.</creatorcontrib><creatorcontrib>Gimbergues, P.</creatorcontrib><creatorcontrib>Azuar, A.-S.</creatorcontrib><creatorcontrib>Tunon de Lara, C.</creatorcontrib><creatorcontrib>Lambaudie, E.</creatorcontrib><creatorcontrib>Houvenaeghel, G.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Nonneville, A.</au><au>Jauffret, C.</au><au>Gonçalves, A.</au><au>Classe, J.-M.</au><au>Cohen, M.</au><au>Reyal, F.</au><au>Mazouni, C.</au><au>Chauvet, M.-P.</au><au>Chopin, N.</au><au>Colombo, P.-E.</au><au>Jouve, E.</au><au>Darai, E.</au><au>Rouzier, R.</au><au>Coutant, C.</au><au>Gimbergues, P.</au><au>Azuar, A.-S.</au><au>Tunon de Lara, C.</au><au>Lambaudie, E.</au><au>Houvenaeghel, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-10</date><risdate>2018</risdate><volume>29</volume><spage>viii62</spage><epage>viii62</epage><pages>viii62-viii62</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32137666</pmid><doi>10.1093/annonc/mdy270.190</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2018-10, Vol.29, p.viii62-viii62
issn 0923-7534
1569-8041
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdy270_190
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T01%3A53%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Benefit%20of%20adjuvant%20chemotherapy%20in%20hormone%20receptor-positive,%20HER2-negative,%20invasive%20lobular%20carcinoma%20of%20the%20breast&rft.jtitle=Annals%20of%20oncology&rft.au=De%20Nonneville,%20A.&rft.date=2018-10&rft.volume=29&rft.spage=viii62&rft.epage=viii62&rft.pages=viii62-viii62&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdy270.190&rft_dat=%3Cpubmed_cross%3E32137666%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32137666&rft_els_id=S0923753419486183&rfr_iscdi=true